METHOD FOR PREPARING 4-[17.BETA.-METHOXY-17.ALPHA.-METHOXYMETHYL-3-OXOESTRA-4,9-DIEN-11.BETA.-YL]BENZALDEHYDE (E)-OXIME (ASOPRISNIL)
The present invention relates to a method for the reliable and reproducible preparation of 4-[17.beta.-methoxy-17.alpha.-methoxymethyl-3-oxoestra-4,9-dien-ll.beta.- yl]benzaldehyde (E)-oxime (asoprisnil) on the pilot and manufacturing scale. Asoprisnil, which is prepared by this method, is distingui...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to a method for the reliable and reproducible preparation of 4-[17.beta.-methoxy-17.alpha.-methoxymethyl-3-oxoestra-4,9-dien-ll.beta.- yl]benzaldehyde (E)-oxime (asoprisnil) on the pilot and manufacturing scale. Asoprisnil, which is prepared by this method, is distinguished by a very good physical stability and is therefore particularly suitable for the manufacture of solid pharmaceutical forms (tablets, coated tablets, etc.).
L'invention porte sur une méthode de préparation de 4-[17.beta.-methoxy-17.alpha.-méthoxyméthyl-3-oxoestra-4,9-dien-11.beta.-yl]benzaldéhyde (e)-oxime (asoprisnil) à l'échelle pilote et à l'échelle de fabrication. L'asoprisnil, préparé par cette méthode, qui se distingue par une très bonne stabilité physique, est donc particulièrement adapté à la fabrication de formes pharmaceutiques solides (comprimés, comprimés pelliculés, etc.). |
---|